Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cdc25 phosphatases: structure, specificity, and mechanism.

Johannes Rudolph1

  • 1Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, USA. rudolph@biochem.duke.edu

Biochemistry
|March 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histone PARylation factor 1: a review of its role in the DNA damage response.

Nucleic acids research·2025
Same author

HTS discovery of PARP1-HPF1 complex inhibitors in cancer.

SLAS discovery : advancing life sciences R & D·2023
Same author

Slow Dissociation from the PARP1-HPF1 Complex Drives Inhibitor Potency.

Biochemistry·2023
Same author

PARP1 and HPF1 team up to flag down DNA-repair machinery.

Nature structural & molecular biology·2023
Same author

Dynamics of endogenous PARP1 and PARP2 during DNA damage revealed by live-cell single-molecule imaging.

iScience·2023
Same author

The structure of the human LACTB filament reveals the mechanisms of assembly and membrane binding.

PLoS biology·2022
Same journal

Aromatic Cage-Directed Azide-Methyllysine Photochemistry for Profiling Nonhistone Interacting Partners of the MeCP2 Methyl-CpG-Binding Domain.

Biochemistry·2026
Same journal

Differential Hydroxypyruvate Processing by <i>E. coli</i> and <i>P. aeruginosa</i> DXP Synthases Reveals Preferential Xylulose 5-Phosphate Formation by the <i>P. aeruginosa</i> Enzyme.

Biochemistry·2026
Same journal

Structural and Functional Characterization of Heterologous Nitrogenase Complexes.

Biochemistry·2026
Same journal

Discovery of Bacterial Unspecific Peroxygenases.

Biochemistry·2026
Same journal

Lactate Biology: Subcellular Routing and Chemical Form Define Function.

Biochemistry·2026
Same journal

Nature's Anaerobic Toolkit: Glycyl Radical Enzymes and Their Expanding Functional and Mechanistic Diversity.

Biochemistry·2026
See all related articles

Cdc25 phosphatases activate Cdk/cyclins to regulate the cell cycle. Their overexpression in cancers makes them key targets for developing novel anticancer drugs, with recent enzymology studies aiding inhibitor design.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Cdc25 phosphatases are crucial activators of cyclin-dependent kinases (Cdk)/cyclins, governing eukaryotic cell cycle progression.
  • Overexpression of Cdc25 phosphatases is linked to poor prognosis across various cancers, highlighting their oncogenic role.
  • Understanding Cdc25 phosphatase function is vital for developing targeted cancer therapies.

Purpose of the Study:

  • To review the structure, specificity, and enzymatic mechanisms of Cdc25 phosphatases.
  • To focus on the activity of Cdc25 phosphatases with their native protein substrates.
  • To consolidate recent enzymological findings for the development of specific Cdc25 inhibitors.

Main Methods:

  • Literature review of existing research on Cdc25 phosphatases.

Related Experiment Videos

  • Analysis of structural, specificity, and mechanistic data.
  • Focus on studies detailing interactions with native protein substrates.

    • Main Results:

    • Significant advancements in understanding Cdc25 phosphatase enzymology have been achieved.
    • Detailed insights into the structure and substrate specificity are available.
    • Mechanistic studies provide a foundation for inhibitor development.

    Conclusions:

    • Cdc25 phosphatases are validated targets for anticancer drug development due to their role in cell cycle regulation and cancer progression.
    • Recent enzymological data facilitates the rational design of specific Cdc25 inhibitors.
    • Further research into Cdc25 phosphatase activity with native substrates will refine therapeutic strategies.